Patent · US Active

Mycoplasma hyopneumoniae vaccine

US9650600B2 · kind B2 · utility

9Cited by

45References

13Claims

0Family size

Assignee

ZOETIS SERVICES LLC · US

Inventors

Jeffrey E. Galvin · Lincoln, US
Gregory Paul Nitzel · Paw Paw, US
John Keith Garrett · North Wilkesboro, US
James R. Kulawik, II · Lincoln, US
Tracy L. Ricker · Portage, US
Megan Marie Smutzer · Kalamazoo, US

Key dates

Filing date	May 14, 2015
Grant date	May 16, 2017
Priority date	—
Expiry date	May 14, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/10034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides an immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.